[ Price : $8.95]
An FDA response to an earlier Orexigen dispute resolution request indicates that CDER supports further discussions on a potentiall...[ Price : $8.95]
FDA approves InSightecs ExAblate MRI-guided focused ultrasound as a therapy to treat pain from bone metastases in patients.[ Price : $8.95]
A Washington, DC federal judge sides with Watson Laboratories and sets a judicial precedent by ordering FDA to approve Watson Labo...[ Price : $8.95]
Federal Register Notice: FDA submits a collection of information on the prescription drug user fee cover sheet to the Office of Ma...[ Price : $8.95]
Federal Register Notice: FDAs Arthritis Advisory Committee will meet 12/20 to discuss a Hemispherx Biopharma NDA for Ampligen to t...[ Price : $8.95]
Actelion Pharmaceuticals submits NDA for Opsumit (macitentan), indicated for treating patients with pulmonary arterial hypertensio...[ Price : $8.95]
FDA approves a Supernus Pharmaceuticals NDA for Oxtellar XR (oxcarbazepine), indicated as adjunctive therapy in treating partial e...[ Price : $8.95]
FDA says it has identified a potential safety issue oculogyric crisis with McNeil Consumers Zyrtec (cetirizine HCl) and updates t...